Regenerative Medicine, ExtraCellular Matrix and Bioadhesives
SherMATRIX Inc. is currently involved in the following areas: Lung surgery, regenerative medicine and complex cell culture. Its most advanced product is a new bioadhesive formulated from an extracellular matrix (ECM) of animal origin for applications in pulmonary surgery. The bioadhesive is being validated in in vitro and in vivo studies. In addition, SherMATRIX offers ECMs derived from various tissues and organs for use in complex cell culture.
To develop and commercialize products and solutions covering various unmet medical needs identified by surgeons and the overall medical community, mostly in the area of regenerative medicine.
Who We Are?
SherMATRIX Inc. was incorporated in February 2020 via love money funding with the goal to value the best results of Dr. Patrick Vermette’s research group, Faculty of Engineering, Université de Sherbrooke.
Our Main Products
A revolutionary formulation of extracellular matrix (ECM) maintaining its ultrastructure
A new bioadhesive (Biological Glue)
Aiming at concrete products and solutions.
Working hand-in-hand for the benefit of the patient.
Identifying unmet needs in partnership with surgeons and health professionals.
If not there at the start, why collaborate then?
1 + 1 = 3 or 4, even 5?
Good ideas come from everywhere!